Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Correspondence] Open letter from Chinese HIV professionals on human genome editing

On Nov 28, 2018, during the Second International Summit on Human Genome Editing in Hong Kong, He Jiankui and colleagues from China claimed that they have edited the human embryonic genome to disable the CCR5 gene in work that resulted in the birth of twin sisters.1 The announcement generated serious concerns relating to scientific ethics. As Chinese professionals engaged in HIV research and prevention, we strongly oppose genome editing on healthy human germline cells and embryos for reproductive purposes and HIV prevention.